• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Emerging Technology Market
Emerging Technology News
Emerging Technology Stocks
  • Emerging Technology Market
  • Emerging Technology News
  • Emerging Technology Stocks
3d-printing-investing

Modelife Announces Collaboration with Exactech Australia

Morag Mcgreevey
Nov. 23, 2015 02:18PM PST
Emerging Technology Investing

Modelife, a Materialise (NASDAQ:MTLS) company, has joined in a collaboration with Exactech Australia. This is intended to bring Modelife’s portfolio of custom implants to the Australian market.

Modelife, a Materialise (NASDAQ:MTLS) company, has joined in a collaboration with Exactech Australia. This is intended to bring Modelife’s portfolio of custom implants to the Australian market.
According to the press release:

As the exclusive independent distributor of Exactech Inc. in the Australian market, Exactech Australia is dedicated to providing innovative products and intuitive instrumentation as well as delivering on Exactech’s promise of being “Surgeon focused, patient driven”. Through their partnership with Mobelife, Exactech Australia will be able to expand their innovative portfolio of hip and shoulder solutions to specialist surgeons in Australia. Of key importance to Mobelife is that this partnership will maintain the close and dynamic collaboration between the surgeon and Mobelife’s expert team, a key aspect in the design process of both aMace and Glenius hip and shoulder implants, which is completely personalized to both the patient and surgeon.
Tim Clijmans, co-founder and CEO of Mobelife and Director of Global Clinical Direct Sales at Materialise, states, “Mobelife is proud to offer all-in-one unique solutions matching the patient’s anatomy and pathology as well as the surgeon’s needs in many countries, so it is exciting to now be bringing our full portfolio to Australian surgeons and their patients with Exactech Australia. Given Exactech’s leadership in upper-extremities, it is especially exciting to collaborate with its distributor to bring our novel shoulder reconstruction solution to the region.”

Click here to read the full press release.


 
australia 3d-printing-investing
The Conversation (0)

Go Deeper

AI Powered
Successful A$4.5m Two Tranche Placement

Successful A$4.5m Two Tranche Placement

Tech Outlook: Australia Edition

Tech Outlook: Australia Edition

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Emerging Technology Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES